on July 29, 2026
The clinical management of mood disorders — ranging from anxiety, irritability, and neurovegetative hyperactivation to depressive syndromes, insomnia, and aggression — requires a systemic and multifactorial understanding. The complex etiopathogenesis of these conditions includes the interaction between genetic susceptibility, environmental toxic load, alterations in the endocrine-metabolic profile, and psychosocial factors.
The fundamental clinical approach aims to explore the primary causes of dysfunction (nutritional, environmental, psychological, and social), integrating cognitive psychology techniques, dietary adjustments, and phytotherapy, with the complementarity of pharmacological therapy in the most severe clinical cases.
Environmental Etiopathogenesis and Neurotoxicity
Chronic exposure to neurotoxic molecules released into the ecosystem, such as pesticides, herbicides, solvents, and heavy metals (lead, mercury, cadmium, aluminum), represents a primary risk factor for nervous tissue. These substances can cross biological barriers and trigger pro-inflammatory cascades and oxidative stress, culminating in neurological and psychiatric symptoms such as headaches, depression, mental confusion, and tremors.
HPA Axis Dysfunction and Tryptophan Metabolism
Chronic stress alters the delicate neuroendocrine balance regulated by the hypothalamic-pituitary-adrenal (HPA) axis. Under conditions of prolonged stress, adrenal cortical hyperactivation leads to a significant increase in cortisol release, which can be clinically observed and monitored through the Adrenal Stress Index by comparing salivary cortisol and dehydroepiandrosterone (DHEA) levels.
Chronic hypercortisolemia exerts a dual harmful effect on the Central Nervous System:
· Neurotoxicity and behavioral alteration: High blood levels of glucocorticoids promote states of anxiety, insomnia, nervousness, manic reactivity, and depression.
· Serotonin and Melatonin Depletion: At the biochemical level, cortisol induces the activation of the tryptophan hydroxylase enzyme (tryptophan 2,3-dioxygenase or TDO). This enzyme diverts the metabolism of the essential amino acid L-tryptophan toward the kynurenine pathway, reducing the amount available and consequently depressing the production of serotonin ("the good-mood hormone") and its derivative melatonin.
Furthermore, serotonin deficiency is directly correlated with dysfunctions in appetite and mood control: nervous instability, a poor sense of gratification, and feelings of emotional loss or incompleteness constitute a powerful risk factor for weight gain.
Behavioral Risk Factors and Lifestyle
To halt neuroendocrine dysregulation, clinical practice must recommend correcting indulgent habits and erroneous dietary styles that fuel the pathology:
· Smoking: Increases systemic cortisol levels and induces a reduction in brain serotonergic receptors, desensitizing the brain to the action of serotonin. At the same time, it causes an acute vitamin C deficiency, reducing the antioxidant defenses intended to eliminate free radicals.
· Alcohol Consumption: Exerts a direct depressive effect on the Central Nervous System, increases the release of adrenal hormones, interferes with various brain functions, alters sleep cycles, and induces hypoglycemia.
· Caffeine Abuse: Can lead to so-called "caffeinism", clinically characterized by anxious states, panic attacks, and headaches.
· Blood Sugar and Carbohydrates: The brain requires a constant supply of sugar. Reactive hypoglycemic fluctuations stimulate the secretion of stress hormones; therefore, a balanced intake of unrefined and complex sugars (distributed in balanced meals) promotes the remission of depressive symptoms.
Key Points of Neuronutrition
A neuroprotective nutritional regimen should be predominantly plant-based, rich in fruit, vegetables, legumes, whole grains, and seeds, drastically limiting saturated fats, salt, food additives, and refined sugars.
The essential micronutrients for the health of the nervous system include:
· B Group and Methyl Donors: Folic acid (Vitamin B9) and Vitamin B12 (and the entire B complex), Thiamine (B1), Choline, Betaine, Dimethylglycine, and Sarcosine, essential for neurotransmitter synthesis and homocysteine metabolism.
· Minerals and Trace Elements: Magnesium and Potassium (found in bran, hazelnuts, almonds, figs, endive, arugula, and soy) to counteract physical and mental fatigue; Manganese, Zinc, and Selenium as antioxidant enzymatic cofactors.
· Amino Acid Precursors and Lipids: L-tryptophan (found in oats, spelt, and wheat) for serotonergic biosynthesis, supported by Taurine, Melatonin, Vitamin E, and essential fatty acids (EFA).
· Flavonoids: Plant polyphenols regulate the reduction of inflammation, modulating the intracellular cascades that control neuronal survival, death, and differentiation, impacting gene expression and mitochondrial function.
Phyto-Psychosomatic Integration and Pharmacology
Psychotropic drugs (anxiolytics, antidepressants, antiepileptics) or other categories of systemic medications slow down the response of the autonomic nervous system (which regulates heart rate, vasoconstriction, muscle blood flow, and adrenal function). In view of a future and gradual suspension of the medication, the organism's "vital force" must be enhanced through a low-toxic, natural diet rich in antioxidants that counteract inflammatory molecules.
In this context, Phyto-Psychosomatics is defined as homeophysiological, as it allows the patient to draw upon their own physiological resources to manage stress and mild or early-stage depression, while supporting conventional therapies in forms of major depression or chronic insomnia.
Adaptogenic, tonic, and anxiolytic plants (such as bacopa, St. John's wort, rhodiola, valerian, griffonia, hawthorn, mugwort, eleuthero, and ginseng) support mental acuity, concentration, and the neuroendocrine response to stress, helping to prevent the numerous systemic complications of anxiety (migraines, gastrointestinal somatization, arrhythmias, menstrual cycle alterations) and depression.
Bibliographic References
1. Russo S, et al. Tryptophan pathway metabolism: relevance for AIDS and depression. Mol Neurobiol. 2003;27(2):133-146.
2. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012;13(10):701-712.
3. Pariante CM, Lightman SL. The HPA axis, glucocorticoid receptor function and depressive illness. Physiol Behav. 2008;94(5):640-649.
4. Spencer SJ, et al. Food for thought: how nutrition impacts cognition and emotion. NPJ Sci Food. 2017;1:7.
5. Sarris J, et al. Nutritional medicine as mainstream in psychiatry. Lancet Psychiatry. 2015;2(3):271-274.
6. Amsterdam JD, et al. A randomized, double-blind, placebo-controlled trial of Rhodiola rosea L. extract in major depressive disorder. Phytomedicine. 2015;22(3):394-399.
7. Lopresti AL, et al. A randomized, double-blind, placebo-controlled trial investigating the anti-anxiety and antidepressant effects of Curcumin and Saffron. J Affect Disord. 2017;207:188-196.
